glp-1 gen 5 Agonists: A Comprehensive Overview but the FDA has not evaluated the medications for safety GLP-1 Medications: Everything You Need
Description
licensed pharmacy
doi: 10.1128/AEM.01641-16 97 PalombaA.TancaA.AbbondioM.SauR.SerraM.MarongiuF.et al
Treatment begins with a low starting dose of 0.25mg, which is gradually increased over several weeks
However, 58.3% (n = 28) declared that they do not consult their doctors before utilizing these medications to lose weight
112 TateD
Phillip M, Mathieu C, Lind M et al (2021) Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies
